Financial News
RxMapper Secures $5.7 Million SAFE Round
June 21, 2024 at 03:00 AM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
(PRLeap.com) Scottsdale, Arizona, June 21, 2024 - RxMapper, a DNA-guided personalized medication platform and telehealth consult practice, announced today it has successfully raised $5.7 million in a SAFE funding round. This investment will further propel RxMapper's mission to transform healthcare by leveraging the power of genomics to identify medications that are likely to be safe and effective based on the patient's DNA, while flagging those that should be avoided."RxMapper's mission is to utilize genomic insights to provide the best possible care for every patient," said Jim Miller, President and Co-Founder of RxMapper. "Our patient-centric approach not only reduces healthcare costs but, most importantly, improves the health and well-being of our patients. For those struggling to find the right medication for their debilitating condition, RxMapper is a new lease on life."
RxMapper's scalable platform is designed to serve populations of all sizes, but RxMapper has chosen to focus on serving small to medium-sized companies with 50 to 5,000 employees through a trusted network of brokers, consultants, and transparent PBMs. Miller emphasized, "This funding will accelerate RxMapper's growth, allowing us to serve an ever-increasing number of companies that prioritize the health, happiness, and productivity of their employees."
About RxMapper
RxMapper is a DNA-guided personalized medication platform and telehealth consult practice. RxMapper sequences and analyzes a patient's DNA and identifies medications that are likely safe and effective for them, while flagging those that should be avoided. This highly personal, DNA-guided approach to medication selection and management leads to improved health outcomes and reduced healthcare costs for both patients and employers.
GET IN TOUCH
Rita Johnson
RxMapper
1-800-950-3230
https://www.rxmapper.com/
You can see the original version and more on PRLeap here: http://www.prleap.com/pr/297423/rxmapper-secures-57-million-safe-round-
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
Stabilus Q3 Earnings Call Highlights ↗
Today 6:02 EDT
AbbVie Quietly Solved Its Biggest Problem—Now What? ↗
August 02, 2026
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
